Literature DB >> 16195667

Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system.

Mark R Garbrecht1, Jonathan M Klein, Thomas J Schmidt, Jeanne M Snyder.   

Abstract

It has been nearly 35 years since Liggins and Howie first reported the benefits of antenatal glucocorticoid (GC) treatment to promote the maturation of the human fetal lung, and nearly that long since Pasqualini and colleagues demonstrated that the human fetal lung actively metabolizes GCs. Since that time, our understanding of the effects of GCs on fetal lung maturation and pulmonary surfactant production has increased dramatically. Similarly, characterization of the enzymes involved in GC metabolism has greatly expanded our understanding of GC signaling in target tissues. In man, the biologically active GC (cortisol) and the biologically inactive GC (cortisone) are interconverted by the tissue-specific expression of the type 1 and type 2 11beta-hydroxysteroid dehydrogenase enzymes (HSD1 and HSD2). Much of the research on GC metabolism in peripheral target tissues has focused on the role of HSD1 in amplifying the effects of GCs in liver and adipose tissue or on the role of HSD2 in blocking the effects of GCs in the kidney and placenta. In contrast, the role of GC metabolism in modulating the effects of GCs on fetal lung maturation and the pulmonary surfactant system in humans is less understood. The goal of this review article is to present a brief overview of the role of GCs in human fetal lung maturation and pulmonary surfactant production, and to familiarize the reader with the biochemistry of the metabolism of natural and synthetic GCs by the HSD enzymes. In addition, we will review data concerning the expression and activity of the HSD enzymes in the human fetal lung and contrast this to what is known about the HSD enzymes in the fetal rodent lung. Although rodents, rabbits, sheep, and several primates have been invaluable model systems for the study of fetal lung development, we have chosen to largely focus this review on human lung, since there are significant differences in GC metabolism between humans and other species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195667     DOI: 10.1159/000088653

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  17 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

2.  Pulmonary interstitial glycogenosis: words of caution.

Authors:  Gail H Deutsch; Lisa R Young
Journal:  Pediatr Radiol       Date:  2010-07-01

3.  On the evolution of development.

Authors:  John S Torday
Journal:  Trends Dev Biol       Date:  2014

4.  Intergenerational transmission of the effects of acculturation on health in Hispanic Americans: a fetal programming perspective.

Authors:  Molly Fox; Sonja Entringer; Claudia Buss; Jessica DeHaene; Pathik D Wadhwa
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

5.  Natural variation in gestational cortisol is associated with patterns of growth in marmoset monkeys (Callithrix geoffroyi).

Authors:  Aaryn C Mustoe; Andrew K Birnie; Austin C Korgan; Jonathan B Santo; Jeffrey A French
Journal:  Gen Comp Endocrinol       Date:  2011-12-26       Impact factor: 2.822

6.  Decreased 11β-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2 double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling.

Authors:  Jingfei Chen; Ritu Mishra; Yaqin Yu; Jeffrey G McDonald; Kaitlyn M Eckert; Lu Gao; Carole R Mendelson
Journal:  FASEB J       Date:  2020-10-18       Impact factor: 5.191

Review 7.  Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings.

Authors:  Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-12       Impact factor: 3.243

Review 8.  Uterotonic plants and their bioactive constituents.

Authors:  Christian W Gruber; Margaret O'Brien
Journal:  Planta Med       Date:  2010-09-15       Impact factor: 3.352

9.  Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn.

Authors:  Heather M Byers; John M Dagle; Jonathan M Klein; Kelli K Ryckman; Erin L McDonald; Jeffrey C Murray; Kristi S Borowski
Journal:  Pediatr Res       Date:  2011-12-21       Impact factor: 3.756

10.  Inhaled Budesonide in Neonatal Respiratory Distress Syndrome of Near-Term Neonates: A Randomized, Placebo-Controlled Trial.

Authors:  Mohamed S Elfarargy; Ghada M Al-Ashmawy; Sally M Abu-Risha; Haidy A Khattab
Journal:  J Pediatr Pharmacol Ther       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.